 |
|
 |
D-penicillamine | A Wisdom Archive on D-penicillamine |  | D-penicillamine A selection of articles related to D-penicillamine |  |
|
More material related to D-penicillamine can be found here:
|
|
|  | |
d-penicillamine
|  | |
|
ARTICLES RELATED TO D-penicillamine | |
 |  |  | D-penicillamine: Encyclopedia II - Rheumatoid arthritis - FeaturesRheumatoid arthritis is a chronic, inflammatory multisystem autoimmune disorder. It commonly affects the joints in a polyarticular manner (polyarthritis). The symptoms that distinguish rheumatoid arthritis from other forms of arthritis are inflammation and soft-tissue swelling of many joints at the same time (polyarthritis). The joints are generally affected in a symmetrical fashion. The pain generally improves with use of the affected joints, and there is usually stiffness of all joints in the morning that lasts over 1 hour. Thus, the pain ...
See also:Rheumatoid arthritis, Rheumatoid arthritis - Features, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Diagnosis, Rheumatoid arthritis - Diagnostic criteria, Rheumatoid arthritis - Blood tests, Rheumatoid arthritis - Pathophysiology, Rheumatoid arthritis - Treatment, Rheumatoid arthritis - DMARDs, Rheumatoid arthritis - Anti-inflammatory agents and analgesics, Rheumatoid arthritis - Other therapies, Rheumatoid arthritis - Eastern philosophies, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Prognosis, Rheumatoid arthritis - Disability, Rheumatoid arthritis - Prognostic factors, Rheumatoid arthritis - Mortality, Rheumatoid arthritis - Prevention, Rheumatoid arthritis - History Read more here: » Rheumatoid arthritis: Encyclopedia II - Rheumatoid arthritis - Features |
|  |
|
 |  |  | D-penicillamine: Encyclopedia II - Chelation therapy - Uses in conventional medicineHeavy metal poisoning is an uncommon medical condition that can have significant effects on nearly every organ system [1]. Mercury, for example, has been strongly implicated as "a potential etiological factor in neurodegeneration" [2]. Chelation therapy is used as a treatment for acute mercury, iron, arsenic, lead, plutonium and other forms of heavy metal poisoning, where the amounts are so high that there is enough risk to the health of the patient to justify the therapy. The buildup of iron ...
See also:Chelation therapy, Chelation therapy - Discovery in medicine, Chelation therapy - Uses in conventional medicine, Chelation therapy - Uses in alternative medicine, Chelation therapy - Calcium chelation therapy Read more here: » Chelation therapy: Encyclopedia II - Chelation therapy - Uses in conventional medicine |
|  |
|
 |  |  | D-penicillamine: Encyclopedia II - Rheumatoid arthritis - PrognosisThe course of the disease varies greatly from patient to patient. Some patients have mild short-term symptoms, but in most the disease is progressive for life.
Rheumatoid arthritis - Disability.
Daily living activities are impaired in most patients.
After 5 years of disease, approximately 33% of patients will not be working
After 10 years, approximately half w ...
See also:Rheumatoid arthritis, Rheumatoid arthritis - Features, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Diagnosis, Rheumatoid arthritis - Diagnostic criteria, Rheumatoid arthritis - Blood tests, Rheumatoid arthritis - Pathophysiology, Rheumatoid arthritis - Treatment, Rheumatoid arthritis - DMARDs, Rheumatoid arthritis - Anti-inflammatory agents and analgesics, Rheumatoid arthritis - Other therapies, Rheumatoid arthritis - Eastern philosophies, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Prognosis, Rheumatoid arthritis - Disability, Rheumatoid arthritis - Prognostic factors, Rheumatoid arthritis - Mortality, Rheumatoid arthritis - Prevention, Rheumatoid arthritis - History Read more here: » Rheumatoid arthritis: Encyclopedia II - Rheumatoid arthritis - Prognosis |
|  |
|
 |  |  | D-penicillamine: Encyclopedia II - Rheumatoid arthritis - TreatmentPharmacological treatment of RA can be divided into disease-modifying antirheumatic drugs (DMARDs), anti-inflammatory agents and analgesics [6]. DMARDs have been found to produce durable remissions and delay or halt disease progression. This is not true of anti-inflammatories and analgesics.
Rheumatoid arthritis - DMARDs.
DMARDs can be further subdivided into xenobiotic agents and biological agents. Xenobiotic agents are those DMARDs that do not occur natural ...
See also:Rheumatoid arthritis, Rheumatoid arthritis - Features, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Diagnosis, Rheumatoid arthritis - Diagnostic criteria, Rheumatoid arthritis - Blood tests, Rheumatoid arthritis - Pathophysiology, Rheumatoid arthritis - Treatment, Rheumatoid arthritis - DMARDs, Rheumatoid arthritis - Anti-inflammatory agents and analgesics, Rheumatoid arthritis - Other therapies, Rheumatoid arthritis - Eastern philosophies, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Prognosis, Rheumatoid arthritis - Disability, Rheumatoid arthritis - Prognostic factors, Rheumatoid arthritis - Mortality, Rheumatoid arthritis - Prevention, Rheumatoid arthritis - History Read more here: » Rheumatoid arthritis: Encyclopedia II - Rheumatoid arthritis - Treatment |
|  |
|
 |  |  | D-penicillamine: Encyclopedia II - Rheumatoid arthritis - Diagnosis
Rheumatoid arthritis - Diagnostic criteria.
The American College of Rheumatology has defined (1987) the following criteria for the diagnosis of rheumatoid arthritis [1].
Morning stiffness of >1 hour.
Arthritis and soft-tissue swelling of >3 of 14 joints/joint groups
Arthritis of hand joints
Symmetric arthritis
Subcutaneous nodules in specific places
Rheumatoid factor at a level above the 95th percentile
Radio ...
See also:Rheumatoid arthritis, Rheumatoid arthritis - Features, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Diagnosis, Rheumatoid arthritis - Diagnostic criteria, Rheumatoid arthritis - Blood tests, Rheumatoid arthritis - Pathophysiology, Rheumatoid arthritis - Treatment, Rheumatoid arthritis - DMARDs, Rheumatoid arthritis - Anti-inflammatory agents and analgesics, Rheumatoid arthritis - Other therapies, Rheumatoid arthritis - Eastern philosophies, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Prognosis, Rheumatoid arthritis - Disability, Rheumatoid arthritis - Prognostic factors, Rheumatoid arthritis - Mortality, Rheumatoid arthritis - Prevention, Rheumatoid arthritis - History Read more here: » Rheumatoid arthritis: Encyclopedia II - Rheumatoid arthritis - Diagnosis |
|  |
|
|
 |  |  | D-penicillamine: Encyclopedia II - Rheumatoid arthritis - PathophysiologyThe cause of RA is still unknown to this day, but has long been suspected to be infectious. It could be due to food allergies or external organisms. Mycoplasma, Erysipelothrix, Epstein-Barr virus, parvovirus and rubella have been suspected but never supported in epidemiological studies. As in other autoimmune diseases, the "mistaken identity" theory suggests that an offending organism causes an immune response that leaves behind antibodies that are specific to that organism. The antibodies are not specific enough, though. They ...
See also:Rheumatoid arthritis, Rheumatoid arthritis - Features, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Diagnosis, Rheumatoid arthritis - Diagnostic criteria, Rheumatoid arthritis - Blood tests, Rheumatoid arthritis - Pathophysiology, Rheumatoid arthritis - Treatment, Rheumatoid arthritis - DMARDs, Rheumatoid arthritis - Anti-inflammatory agents and analgesics, Rheumatoid arthritis - Other therapies, Rheumatoid arthritis - Eastern philosophies, Rheumatoid arthritis - Epidemiology, Rheumatoid arthritis - Prognosis, Rheumatoid arthritis - Disability, Rheumatoid arthritis - Prognostic factors, Rheumatoid arthritis - Mortality, Rheumatoid arthritis - Prevention, Rheumatoid arthritis - History Read more here: » Rheumatoid arthritis: Encyclopedia II - Rheumatoid arthritis - Pathophysiology |
|  |
|
 | |
|
|
More material related to D-penicillamine can be found here:
|
|
|
 | |